Top Markets
#1 Cortex Cortex +32.71%
#2 EXOD EXOD +9.04%
#3 Seeker Seeker +8.43%
#4 ETHGas ETHGas +7.85%
#5 MarsCoin MarsCoin +7.84%
#6 peaq peaq +7.74%
#7 Official Trump Official Trump +6.67%
#8 Solstice Solstice +5.96%
#9 Ethena Staked ENA Ethena Staked ENA +5.92%
#10 DexNet DexNet +5.76%
Coin of the day
Cortex Cortex
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Pozycja w akcjach #6696
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Cena akcji
$30.90
Ostatnia synchronizacja: 2026-08-27
Kapitalizacja rynkowa
$1.90B
Zmiana (1 dzień)
1.68%
Zmiana (1 rok)
859.63%
Kraj
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategoria

Healthcare
Historia stopy dywidendy dla Damora Therapeutics, Inc. (DMRA)
Stopa dywidendy (TTM) dla Damora Therapeutics, Inc. (symbol akcji: DMRA) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Damora Therapeutics, Inc. (DMRA) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH